Intravenous-to-oral switch in anticancer chemotherapy: a focus on docetaxel and paclitaxel.

Koolen, S L W; Beijnen, J H; Schellens, J H M

Koolen, S L W; Beijnen, J H; Schellens, J H M.

Affiliation

Koolen SL; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands.

Clin Pharmacol Ther ; 87(1): 126-9, 2010 Jan.

Article in En | MEDLINE | ID: mdl-19924122

Subject(s)

Antineoplastic Agents/administration & dosage; Paclitaxel/administration & dosage; Taxoids/administration & dosage; Administration, Oral; Animals; Antineoplastic Agents/metabolism; Clinical Trials as Topic/methods; Cytochrome P-450 CYP3A/metabolism; Docetaxel; Humans; Infusions, Intravenous; Paclitaxel/metabolism; Taxoids/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Taxoids / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Clin Pharmacol Ther Year: 2010 Document type: Article Affiliation country: Netherlands Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google